Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer

被引:13
|
作者
Culverwell, A. D. [1 ,2 ]
Chowdhury, F. U. [1 ,2 ]
Scarsbrook, A. F. [1 ,2 ,3 ]
机构
[1] Leeds Teaching Hosp NHS Trust, Dept Clin Radiol, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, Dept Nucl Med, Leeds, W Yorkshire, England
[3] St James Univ Hosp, Dept Nucl Med, Leeds LS9 7TF, W Yorkshire, England
来源
ABDOMINAL IMAGING | 2012年 / 37卷 / 06期
关键词
Colonic carcinoma; Rectal carcinoma; (18)Fluorine fluorodeoxyglucose; Positron emission tomography; computed tomography; Metastatic disease; POSITRON-EMISSION-TOMOGRAPHY; Y-90-GLASS MICROSPHERE TREATMENT; LIVER METASTASES; F-18-FDG PET/CT; COMPUTED-TOMOGRAPHY; EXTRAHEPATIC DISEASE; DIAGNOSTIC-ACCURACY; TREATMENT RESPONSE; ADDITIONAL VALUE; CLINICAL IMPACT;
D O I
10.1007/s00261-012-9855-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. (18)Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography-computed tomography (PET-CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET-CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码:1021 / 1031
页数:11
相关论文
共 50 条
  • [1] Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer
    A. D. Culverwell
    F. U. Chowdhury
    A. F. Scarsbrook
    [J]. Abdominal Imaging, 2012, 37 : 1021 - 1031
  • [2] Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer
    Briggs, R. H.
    Chowdhury, F. U.
    Lodge, J. P. A.
    Scarsbrook, A. F.
    [J]. CLINICAL RADIOLOGY, 2011, 66 (12) : 1167 - 1174
  • [3] Baseline FDG PET-CT parameters as predictors of chemoresponse and survival in metastatic colorectal cancer
    El Mansy, Hazem
    Garcia, Camilo
    Deleporte, Amelie
    Ameye, Lieveke
    Hendlisz, Alain
    Flamen, Patrick
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [4] Implication of FDG-PET/CT in patients with potentially operable colorectal lung metastases
    Uporov, Anton
    Taber, Samantha
    Schwarz, Lope Estevez
    Groene, Joern
    Pilz, Lothar R.
    Foerster, Gregor
    Bittner, Roland
    Pfannschmidt, Joachim
    [J]. INNOVATIVE SURGICAL SCIENCES, 2022, 6 (03): : 89 - 95
  • [5] The role of FDG PET-CT in the evaluation of patients with colorectal cancer. Interobserver study
    Tuncel, M.
    Vargol, S. E.
    Bariskanat, N.
    Topbas, E.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S581 - S581
  • [6] Direct comparison of FDG PET and PET-CT imaging in colorectal cancer.
    Cohade, C
    Osman, M
    Leal, J
    Wahl, RL
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 22P
  • [7] Detection of lymphadenopathy with FDG PET-CT in men with metastatic prostate cancer
    Jadvar, Hossein
    Desai, Bhushan
    Conti, Peter
    Dorff, Tanya
    Groshen, Susan
    Pinski, Jacek
    Quinn, David
    Ye, Wei
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [8] Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
    Erwin Woff
    Alain Hendlisz
    Camilo Garcia
    Amelie Deleporte
    Thierry Delaunoit
    Raphaël Maréchal
    Stéphane Holbrechts
    Marc Van den Eynde
    Gauthier Demolin
    Irina Vierasu
    Renaud Lhommel
    Namur Gauthier
    Thomas Guiot
    Lieveke Ameye
    Patrick Flamen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1792 - 1801
  • [9] Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
    Woff, Erwin
    Hendlisz, Alain
    Garcia, Camilo
    Deleporte, Amelie
    Delaunoit, Thierry
    Marechal, Raphae
    Holbrechts, Stephane
    Van den Eynde, Marc
    Demolin, Gauthier
    Vierasu, Irina
    Lhommel, Renaud
    Gauthier, Namur
    Guiot, Thomas
    Ameye, Lieveke
    Flamen, Patrick
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (10) : 1792 - 1801
  • [10] Role of FDG PET-CT in restaging of patients with bladder cancer
    Yilmaz, Mustafa
    Celen, Zeki
    Erturhan, Sakip
    Kervancioglu, Selim
    Zincirkeser, Sabri
    Karakok, Metin
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2009, 50